SJ Medical
SJ Medical
The healthcare landscape in Tanzania is undergoing a profound transformation, particularly in the management of Non-Communicable Diseases (NCDs). Cardiovascular diseases (CVDs) are now a leading cause of morbidity and mortality in the region. As the Tanzanian government, through the Ministry of Health, prioritizes the expansion of cardiac care centers like the Jakaya Kikwete Cardiac Institute (JKCI), the demand for high-quality, cost-effective Percutaneous Coronary Intervention (PCI) devices has surged.
Information Gain: Unlike generic market reports, our analysis shows that Tanzania's PCI demand is shifting from basic diagnostic angiography to complex therapeutic interventions, requiring micro-guide wires and drug-eluting balloons (DEB) that can handle diverse anatomical challenges found in East African patient populations.
Significant investments in Dar es Salaam, Arusha, and Mwanza are creating new "Cath Labs" (Catheterization Laboratories) requiring steady OEM supply chains.
Tanzanian healthcare procurement managers are increasingly seeking high-performance alternatives to Western brands that offer the same clinical outcomes at a sustainable cost.
As a leading PCI manufacturer and exporter, we recognize that the future of interventional cardiology in Tanzania lies in the "Minimally Invasive" revolution. Our technical roadmap for the Tanzania market focuses on three core pillars:
At Hangzhou SJ Medical Co., Ltd., we utilize "Factory 4.0" principles to bridge the gap between high-volume manufacturing and artisanal precision. For our Tanzanian partners, this means a Supply Chain Resilience that protects against global logistics volatility.
Our 5,000 sqm modern facility includes a million-class clean workshop. By using automated laser welding and precision balloon forming, we reduce human error to near zero, ensuring that every PTCA catheter arriving at a Tanzanian hospital performs exactly like the last.
Navigating the Tanzania Medicines and Medical Devices Authority (TMDA) requirements is critical for any exporter. SJ Medical provides full documentation support, including ISO 13485, CE Certification, and CFDA approvals. We go beyond simple exporting by offering:
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems. Through continuous innovation and strong R&D capabilities, the company has obtained multiple patents and international certifications, laying a solid foundation for sustainable growth in both domestic and global markets.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical processes.
The company is supported by a highly experienced technical team, many of whom have been engaged in the medical device industry for decades. Under the leadership of senior engineers, SJ Medical maintains strict quality control and continuously improves its manufacturing processes to ensure product reliability and consistency.
SJ Medical has established long-term partnerships with clients across Europe, Asia, the Middle East, and Africa. Its products are currently distributed in countries such as Finland, Italy, Spain, France, the Netherlands, India, Indonesia, Turkey, and Egypt, among others. The company continues to expand its international footprint and strengthen its global presence.
